Needle Nerve Contact in Ultrasound Guided Femoral Block

NCT ID: NCT01554722

Last Updated: 2012-03-15

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

UNKNOWN

Clinical Phase

NA

Total Enrollment

44 participants

Study Classification

INTERVENTIONAL

Study Start Date

2011-11-30

Study Completion Date

2012-03-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Ultrasound-guided femoral nerve block is a common regional anesthesia technique. The optimal method of needle guidance (in-plane versus out-of-plane) with regards to the block efficacy and avoidance of needle-nerve contact has not been established. In this study the investigators tests the hypothesis that the incidence of needle-nerve contact is higher with the needle insertion in an out-of-plane than with the in-plane approach.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Fourty-four patients with hip fracture (American Society of Anesthesiologists physical status 1-3) are being randomized to receive the femoral block with an out-of-plane (needle inserted at a 45°-60° angle 1 cm caudal to the midpoint of the ultrasound probe just above the femoral nerve) or an in-plane technique (needle inserted 0.5 cm from the side of the probe lateral to the femoral nerve). The data collected includes the depth of needle insertion at the endpoint before injection, response to nerve stimulation, distribution of the injected volume in relation to the nerve (anterior vs posterior, the latter indicating impalement), block efficacy at 20 minutes and 24 hours, and any signs of nerve injury).

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Peripheral Nerve Injury

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

PREVENTION

Blinding Strategy

TRIPLE

Participants Caregivers Outcome Assessors

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

in plane needle placement

Group Type EXPERIMENTAL

Needle placement

Intervention Type PROCEDURE

In plane versus out of plane needle placement techniques

out of plane needle placement

Group Type EXPERIMENTAL

Needle placement

Intervention Type PROCEDURE

In plane versus out of plane needle placement techniques

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Needle placement

In plane versus out of plane needle placement techniques

Intervention Type PROCEDURE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* ASA physical status 1-3 patients
* Diagnosis of trochanteric or cervical hip fracture
* Hip replacement under spinal anesthesia

Exclusion Criteria

* Patients under the age of 65 years or over the age of 90 years
Minimum Eligible Age

18 Years

Maximum Eligible Age

65 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

Yes

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Hospital Clinic of Barcelona

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Ana Ruiz

MD

Responsibility Role PRINCIPAL_INVESTIGATOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Xavier Sala-Blanch, MD

Role: PRINCIPAL_INVESTIGATOR

University Clinic Barcelona

Ana Ruiz, MD

Role: PRINCIPAL_INVESTIGATOR

University of Barcelona

Julia Martinez-Ocon, MD

Role: STUDY_CHAIR

University of Barcelona

Maria J Carretero, MD

Role: STUDY_CHAIR

University of Barcelona

Gerard Sánchez-Etayo, MD

Role: STUDY_CHAIR

University of Barcelona

Admir Hadzic, Prof Dr

Role: STUDY_DIRECTOR

Columbia University St Luke's Hospital

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

St Luke'S Roosevelt Hospital, Columbia University

New York, New York, United States

Site Status RECRUITING

University of Barcelona

Barcelona, , Spain

Site Status RECRUITING

Countries

Review the countries where the study has at least one active or historical site.

United States Spain

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

Ana Ruiz, MD

Role: CONTACT

0034932275558

Xavier Sala-Blanch, MD

Role: CONTACT

Facility Contacts

Find local site contact details for specific facilities participating in the trial.

Xavier Sala-Blanch, MD

Role: primary

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

R6345

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.